Posted: 1 month(s) and 11 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: crwefinance.com

CRWEFinance.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From CRWEFinance.com

________________________________________

Be sure to check out more news at crwefinance.ning.com as well.

********************************************************************************

LKQ Corporation (Nasdaq:LKQX), the largest nationwide provider of aftermarket collision replacement parts, recycled light vehicle parts, and refurbished bumpers and wheels, will release its financial results for its fourth quarter and full year 2009 on Thursday, February 25, 2010, before the market opens.

Rand Capital Corporation (Nasdaq:RAND) ("Rand"), a business development company (BDC) that provides capital and managerial expertise for small to medium-sized private companies, announced its financial results for the fourth quarter ended December 31, 2009 highlighting a net asset value of $3.40 per share, a decrease of ($0.02) from September 30, 2009. At the end of the fourth quarter, Rand's total investment portfolio was valued at $24.3 million, which exceeds its cost basis of $14.8 million, reflecting $9.5 million in net unrealized appreciation.

Using the Company’s BC-SeraPro platform, Power3 Medical Products, Inc. (PWRM.OB) used protein biomarkers to distinguish women with breast cancer from those with benign abnormal breast conditions and with normal breasts with sensitivities and specificities in the 80%-90% range, in retrospective banked and prospective newly drawn samples from patients and controls. The biomarkers also distinguish between women with purely invasive primary breast cancer and women who also have ductal carcinoma in situ, which is often missed in mammograms.In addition, following the “Principals of Omic Medicine” that Dr. Goldknopf promoted at the international scientific meetings in the US and China, the company has disclosed methods for making biomarker specific antibodies for development of a user friendly commercial test for breast cancer.

***********Advertisement***********

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).

Member Rating: 0 0